Safety and Efficacy Analysis of FRED® Embolic Device in Aneurysm Treatment

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

February 28, 2017

Study Completion Date

December 31, 2017

Conditions

Intracranial Aneurysms

Interventions

DEVICE

FRED®

Flow Re-Direction Endoluminal Device

All Listed Sponsors

lead

Microvention-Terumo, Inc.

INDUSTRY

NCT02921698 - Safety and Efficacy Analysis of FRED® Embolic Device in Aneurysm Treatment | Biotech Hunter | Biotech Hunter